Results 11 to 20 of about 26,046 (277)
Future evaluation of antiarrhythmic therapy
American Heart Journal, 1994 The expension of antiarrhythmic therapy beyond pharmacologic agents to include surgary, devices, and ablation procedures, plus the reaffirmation by the Cardiac Arrhythmia Suppression Trial (CAST) of the need for concurrent placebo-controlled trials to ...
Kessler, Kenneth M +6 more
core +3 more sources
Heart Failure Clinics, 2011 The implantable cardioverter-defibrillator (ICD) is the standard of care in patients with ischemic and nonischemic cardiomyopathy who are at high risk for arrhythmic events and sudden cardiac death.
exaly +3 more sources
SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE
Клиническая практика, 2017 Atrial fibrillation is widespread in population. It determines extensive use of antiarrhythmic drugs such as amiodarone. Thyroid lesion is one of common side effects of this therapy. The article describes a clinical case of photosensitivity’s development
N P Dorofeeva +7 more
doaj +2 more sources
Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
Biomedicines, 2023 Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable progressive myocardial disorder that predisposes patients to ventricular arrhythmias and sudden cardiac death.
Sean P. Gaine, Hugh Calkins
doaj +2 more sources
EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
Рациональная фармакотерапия в кардиологии, 2015 Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy of preventive antiarrhythmic therapy in patients with paroxysmal atrial fibrillation (AF).Material and methods. 40 patients with paroxysmal AF were involved in open-
L. N. Chikhireva +3 more
doaj +3 more sources
Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia [PDF]
, 2022 [EN]In patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (ICD), catheter ablation and antiarrhythmic drugs (AADs) reduce ICD shocks, but the most effective approach remains uncertain.
Fernández-Avilés, Francisco J. +13 more
core +1 more source
Reviews in Cardiovascular Medicine, 2022 Background: Catheter ablation is an effective treatment for atrial fibrillation (AF), primarily performed in patients who fail antiarrhythmic drugs. Whether early catheter ablation, as first-line therapy, is associated with improved clinical outcomes ...
Aminah Abdul Razzack +16 more
doaj +1 more source
Zero-fluoroscopy approach for ablation in Wolf -Parkinson – White syndrome during pregnancy
Heart Vessels and Transplantation, 2022 Paroxysmal supraventricular tachycardias during pregnancy are rare; however, it can be a therapeutic challenge because of limitations about use of antiarrhythmic drug therapy and catheter ablation indication, due to the risk of radiation exposure to the ...
Ulises Rojel +5 more
doaj +1 more source
Potassium channels as targets for antiarrhythmic therapy. [PDF]
Heart RhythmChiamvimonvat N, Zheng Y, Zhang M.
europepmc +4 more sources
Feasibility of Radiofrequency Catheter Ablation in the Treatment of Atrial Fibrillation
Український журнал серцево-судинної хірургії, 2020 Atrial fibrillation (AF) is a worldwide epidemic that has hit about 33 million people. In clinical studies, the efficacy of antiarrhythmic therapy and catheter ablation in the treatment of AF was compared, and controversial results were obtained ...
M. Meshkova, A. Doronin
doaj +1 more source